By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today announced that it has received "Moderate Complexity" status from the US Food and Drug Administration for its BD Max GBS Assay for Group B Streptococcus on the BD Max System, which could hasten molecular testing for the disease.

FDA granted "Moderate Complexity" to the assay under CLIA regulations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.